Contribution of vascular risk factors to the progression in Alzheimer disease
- PMID: 19273753
- PMCID: PMC3105324
- DOI: 10.1001/archneur.66.3.343
Contribution of vascular risk factors to the progression in Alzheimer disease
Abstract
Background: Vascular factors including medical history (heart disease, stroke, diabetes, and hypertension), smoking, and prediagnosis blood lipid measurements (cholesterol: total, high-density lipoprotein, low-density lipoprotein [LDL-C], and triglyceride concentrations) may be predictors for progression of Alzheimer disease (AD).
Objective: To determine whether prediagnosis vascular risk factors are associated with progression of AD.
Design: Inception cohort followed up longitudinally for a mean of 3.5 (up to 10.2) years.
Setting: Washington Heights/Inwood Columbia Aging Project, New York, New York. Patients One hundred fifty-six patients with incident AD (mean age at diagnosis, 83 years). Main Outcome Measure Change in a composite score of cognitive ability from diagnosis onward.
Results: In generalized estimating equation models (adjusted for age, race/ethnicity, and years of education), higher cholesterol (total cholesterol and LDL-C) concentrations and history of diabetes were associated with faster cognitive decline. Each 10-U increase in cholesterol and LDL-C was associated with a 0.10-SD decrease in cognitive score per year of follow-up (P < .001 for total cholesterol; P = .001 for LDL-C). High-density lipoprotein cholesterol and triglyceride concentrations were not associated with rate of decline. A history of diabetes was associated with an additional 0.05-SD decrease in cognitive score per year (P = .05). History of heart disease and stroke were associated with cognitive decline only in carriers of the apolipoprotein E epsilon4 (APOE-epsilon4) gene. In a final generalized estimating equation model that included high-density lipoprotein cholesterol and LDL-C concentrations and history of diabetes, only higher LDL-C was independently associated with faster cognitive decline.
Conclusion: Higher prediagnosis total cholesterol and LDL-C concentrations and history of diabetes were associated with faster cognitive decline in patients with incident AD, which provides further evidence for the role of vascular risk factors in the course of AD.
Figures
Similar articles
-
Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.PLoS Med. 2017 Mar 28;14(3):e1002265. doi: 10.1371/journal.pmed.1002265. eCollection 2017 Mar. PLoS Med. 2017. PMID: 28350817 Free PMC article.
-
Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.Neurology. 2006 Jan 24;66(2):223-7. doi: 10.1212/01.wnl.0000194507.39504.17. Neurology. 2006. PMID: 16434658 Free PMC article.
-
Low-density lipoprotein cholesterol and the risk of dementia with stroke.JAMA. 1999 Jul 21;282(3):254-60. doi: 10.1001/jama.282.3.254. JAMA. 1999. PMID: 10422994
-
Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline.Aging Clin Exp Res. 2006 Apr;18(2):144-8. doi: 10.1007/BF03327430. Aging Clin Exp Res. 2006. PMID: 16702784 Review.
-
Lipoproteins, vascular-related genetic factors, and human longevity.Rejuvenation Res. 2007 Dec;10(4):441-58. doi: 10.1089/rej.2007.0537. Rejuvenation Res. 2007. PMID: 17990970 Review.
Cited by
-
Cerebrovascular lesions induce transient β-amyloid deposition.Brain. 2011 Dec;134(Pt 12):3697-707. doi: 10.1093/brain/awr300. Epub 2011 Nov 26. Brain. 2011. PMID: 22120142 Free PMC article.
-
DHA may prevent age-related dementia.J Nutr. 2010 Apr;140(4):869-74. doi: 10.3945/jn.109.113910. Epub 2010 Feb 24. J Nutr. 2010. PMID: 20181786 Free PMC article. Review.
-
Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults.Brain Commun. 2022 Feb 18;4(1):fcac035. doi: 10.1093/braincomms/fcac035. eCollection 2022. Brain Commun. 2022. PMID: 35233525 Free PMC article.
-
Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients.J Cereb Blood Flow Metab. 2010 Nov;30(11):1817-20. doi: 10.1038/jcbfm.2010.140. Epub 2010 Aug 18. J Cereb Blood Flow Metab. 2010. PMID: 20717123 Free PMC article.
-
The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.J Neurovirol. 2019 Oct;25(5):661-672. doi: 10.1007/s13365-018-0702-9. Epub 2019 Jan 22. J Neurovirol. 2019. PMID: 30671777 Free PMC article. Review.
References
-
- Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, Pondal M, Vivancos J, Del Ser T. Poststroke Dementia: Clinical Features and Risk Factors. Stroke. 2000 July 1;31(7):1494–1501. - PubMed
-
- DeCarli C. The role of cerebrovascular disease in dementia. Neurologist. 2003;9(3):123–136. - PubMed
-
- Korczyn AD. The underdiagnosis of the vascular contribution to dementia. Journal of the Neurological Sciences. 2005;229–230:3–6. - PubMed
-
- Luchsinger JA, Mayeux R. Cardiovascular risk factors and Alzheimer’s disease. Curr Atheroscler Rep. 2004;6(4):261–266. - PubMed
-
- Honig LS, Tang M-X, Albert S, et al. Stroke and the Risk of Alzheimer Disease. Arch Neurol. 2003 December 1;60(12):1707–1712. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR000645/RR/NCRR NIH HHS/United States
- R01 AG034189/AG/NIA NIH HHS/United States
- AG007232/AG/NIA NIH HHS/United States
- T32 NS007153/NS/NINDS NIH HHS/United States
- P01-AG07232/AG/NIA NIH HHS/United States
- Z01 AG000261/ImNIH/Intramural NIH HHS/United States
- R01 AG037212/AG/NIA NIH HHS/United States
- T32 AG000261/AG/NIA NIH HHS/United States
- 5T32NS007153-22/NS/NINDS NIH HHS/United States
- L30 AG026603/AG/NIA NIH HHS/United States
- P01 AG007232/AG/NIA NIH HHS/United States
- K23 AG032899/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous